Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
WALTHAM, Mass., July 22, 2026 /PRNewswire/ — Mentari Therapeutics, Inc. (“Mentari”), a privately-held biotechnology company developing therapies for…